A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
R. Charles Coombes, Fatima Cardoso, Nicolas Isambert, Thierry Lesimple, Patrick Soulié, Concepcion Peraire, Veronique Fohanno, Anne Kornowski, Tauhid Ali, Peter Schmid…show all 10hideТом:
140
Мова:
english
DOI:
10.1007/s10549-013-2597-8
Date:
July, 2013
Файл:
PDF, 406 KB
english, 2013
File converter
Більше результатів пошуку
More benefits 
